Understand the source comparison
5-Amino-1MQ vs Other Metabolic Compounds: Timeline Comparison
5-Amino-1MQ NNMT inhibition 48–72 hours 4–6 weeks 8–12 weeks Slower onset than receptor agonists but sustained metabolic reprogramming. Better suited for long-duration studies NMN (Nicotinamide Mononucleotide) NAD+ precursor 2–4 hours (oral) 6–8 weeks 12–16 we
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- 5-Amino-1MQ
- NNMT inhibition
- 48–72 hours
- 4–6 weeks
- 8–12 weeks
- Slower onset than receptor agonists but sustained metabolic reprogramming. Better suited for long-duration studies
- NMN (Nicotinamide Mononucleotide)
- NAD+ precursor
- 2–4 hours (oral)
- 6–8 weeks
- 12–16 weeks
- Rapid NAD+ boost but limited tissue penetration. Hepatic uptake preferential over adipose
- Resveratrol
- SIRT1 activator
- Indirect (12–24 hours)
- 16–20 weeks
- Inconsistent bioavailability. Effects highly dose-dependent and variable across studies
- GW501516 (Cardarine)
- PPARδ agonist
- No direct NAD+ effect
- 2–3 weeks
- Faster phenotypic changes but works through different pathway. Combines well with NNMT inhibitors in multi-target protocols